Literature DB >> 34980592

Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies.

Takuma Furukawa1,2, Yuichiro Nishida3, Megumi Hara3, Chisato Shimanoe4, Kayoko Koga3, Chiharu Iwasaka3, Yasuki Higaki5, Keitaro Tanaka3, Ryoko Nakashima6, Hiroaki Ikezaki6,7, Asahi Hishida8, Takashi Tamura8, Yasufumi Kato8, Yudai Tamada8, Keitaro Matsuo9,10, Hidemi Ito11,12, Haruo Mikami13, Miho Kusakabe13, Rie Ibusuki14, Keiichi Shibuya14,15, Sadao Suzuki16, Hiroko Nakagawa-Senda16, Etsuko Ozaki17, Daisuke Matsui17, Kiyonori Kuriki18, Yasuyuki Nakamura19, Aya Kadota19, Kokichi Arisawa20, Sakurako Katsuura-Kamano20, Kenji Takeuchi8, Kenji Wakai8.   

Abstract

INTRODUCTION: Healthy diet and physical activity (PA) are essential for preventing type 2 diabetes, particularly, a combination of diet and PA. However, reports on interaction between PA and diet, especially from large epidemiological studies, are limited. We investigated the effect of interaction between PA and macronutrient intake on hemoglobin A1c (HbA1c) levels in the general population. RESEARCH DESIGN AND METHODS: We conducted a cross-sectional study of 55 469 men and women without diabetes who participated in the baseline survey of the Japan Multi-Institutional Collaborative Cohort Study. A self-administered questionnaire ascertained PA and macronutrient intake (carbohydrate, fat, and protein). Multiple linear regression analyses were performed to adjust for confounding variables and examine the interactions. In addition, we conducted a longitudinal study during a 5-year period within a subcohort (n=6881) with accelerometer-assessed PA data.
RESULTS: Overall, PA had a weak inverse association (β=-0.00033, p=0.049) and carbohydrate intake had a strong positive association (β=0.00393, p<0.001) with HbA1c. We observed a tendency of interactions between PA and carbohydrate or fat intake, but not protein intake, on HbA1c levels after adjusting for age, sex, study area, total energy intake, alcohol consumption, smoking, and medication for hypertension or hypercholesterolemia (Pinteraction=0.054, 0.006, and 0.156, respectively). The inverse associations between PA and HbA1c level were more evident in participants with high-carbohydrate (or low-fat) intake than in participants with low-carbohydrate (or high-fat) intake. Although further adjustment for body mass index slightly attenuated the above interactions (Pinteraction=0.098 for carbohydrate and 0.068 for fat), the associations between PA and HbA1c level in stratified analyses remained unchanged. Similar associations and interactions were reproduced in the longitudinal study.
CONCLUSIONS: The present results suggest that the effect of PA on HbA1c levels is modified by intake of macronutrient composition. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; exercise; glycated hemoglobin; nutrients

Mesh:

Substances:

Year:  2022        PMID: 34980592      PMCID: PMC8724736          DOI: 10.1136/bmjdrc-2021-002479

Source DB:  PubMed          Journal:  BMJ Open Diabetes Res Care        ISSN: 2052-4897


Physical activity (PA) is associated with lower hemoglobin A1c (HbA1c) level. Macronutrient (carbohydrate, fat, and protein) intake also affects HbA1c level. This large-scale population-based cross-sectional study revealed the effect of interactions between PA and macronutrient intake on HbA1c level. The inverse associations between PA and HbA1c level were more evident in participants with higher carbohydrate or lower fat intake than in participants with lower carbohydrate or higher fat intake. Moreover, these interactions and associations were reproduced in the longitudinal study. This study shows that the control of HbA1c could become more effective and sustainable by implementing an optimized diet and PA according to possible interactions as observed in this study.

Introduction

In 2019, the number of people with diabetes was estimated to be 463 million globally, and the prevalence continues to increase.1 2 Diabetes causes various complications and significant socioeconomic burden; it also affects health and quality of life. Hemoglobin A1c (HbA1c) is a good indicator of average blood glucose levels over previous 2–3 months and is used to diagnose diabetes. Studies have reported that people with type 2 diabetes have higher HbA1c levels long before the onset of diabetes than those of people without diabetes.3 4 Type 2 diabetes accounts for >90% of all diabetes cases and is caused by complex factors, such as socioeconomic, environmental, and genetic factors, among which lifestyle factors, such as diet and physical activity (PA), are considered as the most important.5 Lifestyle modification is useful for type 2 diabetes prevention and treatment. It has been reported that lifestyle interventions, including diet, reduce the incidence of type 2 diabetes.6 7 Exercise is also effective for the prevention and treatment of type 2 diabetes.8 PA in daily life is important, as well as exercise, and there is evidence showing the effects of PA on the prevention and treatment of type 2 diabetes.9 Diet and PA are also closely related in terms of energy homeostasis, intervention studies on type 2 diabetes are often conducted with a combination of diet and PA. In two systematic review reports, the effect of intervention with a combination of diet and PA on blood glucose control was consistently positive, whereas the effect of diet or PA intervention alone was not consistent.10 11 Energy is mainly produced from macronutrients (carbohydrate, fat, and protein), but some studies have reported no relationship between the intake of carbohydrate or fat and the onset of type 2 diabetes,12 13 and there is no clear evidence to determine the most effective macronutrient intake composition for blood glucose control.5 14 Moreover, there is evidence showing that PA intervention alone had no effect in reducing the risk of developing type 2 diabetes.10 In contrast, a study demonstrated that the effect of exercise intervention on blood glucose levels could be modified according to the intake of macronutrient composition.15 Based on these findings, it is considered that the interaction between diet and PA is an important factor for type 2 diabetes prevention and treatment. However, evidence on the effect of interaction between diet and PA on blood glucose or HbA1c levels is limited, and no large epidemiological study has been conducted. We hypothesized that the effect of PA on HbA1c levels could be modified by the status of nutritional intake. To explore our hypothesis, we conducted this study to investigate the effect of interaction between PA and macronutrient (carbohydrate, fat, and protein) intake on HbA1c levels in the Japanese general population.

Research design and methods

Study participants

Participants were recruited by the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study, which comprised a large cohort that has been followed up to explore the relationship between lifestyle, genotype, blood composition, and the risk of developing various diseases. The details of the J-MICC Study have been described in a previous report.16 17 The J-MICC Study was initiated in 2005, and participants aged 35–69 years were voluntarily enrolled from the following 13 sites in Japan: Aichi, Chiba, Fukuoka, Iga, Kagoshima, Kyushu-KOPS, Kyoto, Okazaki, Sakuragaoka, Saga, Shizuoka-Daiko, Takashima, and Tokushima subcohorts. In the present cross-sectional study, we used data (V.20201218) obtained from 92 530 participants nationally registered between 2004 and 2008. In the analysis, we excluded 37 446 participants who had missing data on HbA1c level (n=31 093), a history of diabetes-related diseases, such as diabetes, stroke, heart disease, liver disease, and cancer (n=5982), and a dietary total energy intake of <500 or >4000 kcal/day or outliers corresponding to the top and bottom 0.1% of macronutrient intake data (n=371). Consequently, data from 55 084 participants aged 35–69 years were included in the analysis (figure 1), among whom some had missing data on alcohol consumption (n=69), smoking (n=193), medication for hypertension or hypercholesterolemia (n=45), and body mass index (BMI) (n=12).
Figure 1

Flow chart of the process for selecting study participants. HbA1c, hemoglobin A1c; J-MICC, Japan Multi-Institutional Collaborative Cohort.

Flow chart of the process for selecting study participants. HbA1c, hemoglobin A1c; J-MICC, Japan Multi-Institutional Collaborative Cohort. In the longitudinal study, we used data obtained from 8454 participants who completed the baseline survey and the second survey after 5 years in a subcohort of the J-MICC Study (J-MICC Saga).18 In the analysis, we excluded 1573 participants who had missing data on HbA1c level or PA (n=704), a history of diabetes-related diseases at baseline (n=832), and a dietary total energy intake of <500 or >4000 kcal/day or outliers corresponding to the top and bottom 0.1% of macronutrient intake data (n=37). Consequently, 6881 participants were included in the longitudinal analysis.

Questionnaire and measurements

Self-administered questionnaires were used to collect data on PA, eating habits, alcohol consumption, smoking, medication, and disease history. Height and weight were measured to the nearest 0.1 cm and 0.1 kg, respectively, and BMI was calculated from the measured height and weight. Systolic blood pressure and diastolic blood pressure were measured by anthropometry at the study site. HbA1c level was measured using latex aggregation immunoassay at each study center using blood samples of participants, and the measurement results were collected. The measured HbA1c value (Japan Diabetes Society (JDS) value) was converted into the National Glycohemoglobin Standardization Program (NGSP) equivalent value using the following formula: HbA1c (NGSP [%])=1.02×HbA1c (JDS [%])+0.25.19 Moreover, HbA1c value (International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) value) was calculated using the following formula: HbA1c (IFCC [mmol/mol])=10.93×HbA1c (NGSP [%])−23.50.20 In the present study, the analysis was conducted using HbA1c (NGSP (%)). In the longitudinal study, although the data collection and measurement methods were the same as above, objective PA was additionally assessed using the accelerometer.

PA assessment

PA was evaluated in terms of metabolic equivalents (METs) from the questionnaire data, where MET values of ≥3 were assessed as PA. In the present study, PA was defined as total PA, including daily and leisure-time activity. Participants reported the average time spent per day for each of the following daily activities: heavy physical work time (assigned MET intensity: 4.5 METs) and walking time (3.0 METs). Average time was assigned as follows: none (0), <1 hour/day (0.5), 1–<3 hours/day (2.0), 3–<5 hours/day (4.0), 5–<7 hours/day (6.0), 7–<9 hours/day (8.0), 9–<11 hours/day (10.0), and ≥11 hours/day (12.0). PA (MET×hour/day) in daily life was estimated by multiplying the average time and assigned MET intensity in each activity. For leisure-time activity, participants reported the frequency and average duration for each of the activities as follows: low-intensity PA (such as walking and golf) (assigned MET intensity: 3.4 METs), moderate-intensity PA (such as jogging and swimming) (7.0 METs), and high-intensity PA (such as marathon running and martial arts) (10 METs). Frequency was assigned for daily average as follows: none (0), 1–3 times/month (0.1), 1–2 times/week (0.2), 3–4 times/week (0.5), and 5–6 times/week (0.8). Average duration was assigned for average hours as follows: <30 min (0.3), 30 min–<1 hour (0.8), 1–<2 hours (1.5), 2–<3 hours (2.5), 3–<4 hours (3.5), and ≥4 hours (4.5). The PA (METs×hour/day) of leisure-time activity was estimated by multiplying the frequency, average duration, and assigned MET intensity in each activity. In the present study, PA was calculated by summing the daily and leisure-time activities. In the longitudinal study, to measure PA, the participants were instructed to attach a single-axis accelerometer (Life-corder, Suzuken Co, Nagoya, Japan) during all waking hours (except when bathing and sleeping) for 10 days, as described in a previous report.21 PA was evaluated for MET values ≥3, and PA (METs×hour/day) was calculated as a sum of mathematical products between corresponding METs and the time spent at corresponding intensity levels.

Dietary assessment

A validated short Food Frequency Questionnaire (FFQ) was used for dietary assessment,22–25 and the total energy and macronutrient (carbohydrate, fat, and protein) intake were estimated. Participants answered the average intake of 46 foods over the past year. The amounts and frequencies were confirmed for three staple foods (rice, bread, and noodles) eaten at breakfast, lunch, and supper. The frequency for the staple foods was assigned as follows: almost none (0), 1–3 times/month (0.1), 1–2 times/week (0.2), 3–4 times/week (0.5), 5–6 times/week (0.8), and daily (1). The staple food eaten at each meal was counted as bowls/day for rice and noodles or slices (or rolls)/day for bread, and the values obtained for three meals were summed. For the remaining 43 foods, only frequency options were provided, as follows (assigned daily frequencies): almost none (0), 1–3 times/month (0.1), 1–2 times/week (0.2), 3–4 times/week (0.5), 5–6 times/week (0.8), once/day (1), twice/day (2), and ≥3 times/day (3); the mean portion size was assigned to each food based on a survey of the Japanese participants using 1-day weighed diet records.26 The total energy and macronutrient (carbohydrate, fat, and protein) intake were calculated using a program developed by the Department of Public Health, Nagoya City University School of Medicine, based on the standard tables of food consumption in Japan.22 In the program, the energy from alcohol consumption was included in the total energy intake calculated. A validation study was conducted by comparing the total energy intake and nutrients estimated using the FFQ and 3-day weighed diet records.23 The correlation coefficients were 0.49 (total energy intake), 0.86 (carbohydrate), 0.62 (fat), and 0.50 (protein). The reproducibility correlation coefficient of 1-year intervals in this FFQ ranged from 0.73 to 0.84.

Statistical analysis

In the cross-sectional study, participants were stratified into quartiles (Q1–Q4) based on the macronutrient (carbohydrate, fat, and protein) intake percentage of the total energy intake. We used analysis of variance (for continuous variables) and the χ2 test (for categorical variables) to compare participant characteristics according to the macronutrient quartiles. To examine the overall effects of PA (METs×hour/day) or macronutrient intake (% of total energy intake) on HbA1c (%) and to analyze the effect of interactions between PA and macronutrient intake on HbA1c, we conducted multiple regression analyses using the general linear model. Moreover, we examined the associations between PA and HbA1c in stratified analyses by quartiles of macronutrient intake. Model 1 was adjusted for age (years), sex, study area, total energy intake (kcal/day), alcohol consumption (ethanol g/day), smoking amount (cigarettes/day), and medication for hypertension (yes/no) or hypercholesterolemia (yes/no). Model 2 was further adjusted for BMI (kg/m2). In the longitudinal study, we examined whether the change in PA (METs×hour/day) between baseline and follow-up (ie, the value at baseline subtracted from the value at follow-up) was associated with the corresponding change in HbA1c (%) and whether this association was modified by quartile-stratified macronutrient intake (carbohydrate, fat, and protein as % energy) at baseline using multiple linear regression analyses. Stratified analyses by quartiles of macronutrient intake at baseline were also performed. Model 1 was adjusted for age at baseline (years), sex, changes (ie, the value at baseline subtracted from the value at follow-up) in each of total energy intake (kcal/day), macronutrient intake (kcal/day), alcohol consumption (ethanol g/day) and smoking amount (cigarettes/day), and medication for each of diabetes (yes/no at follow-up), hypertension (no/no, no/yes, yes/no, and yes/yes at baseline/follow-up) and hypercholesterolemia (categorized as identical to hypertension). Model 2 was further adjusted for BMI change (kg/m2). All analyses were conducted using the SAS statistical software package (V.9.4 for Windows; SAS Institute).

Results

Study participant characteristics are summarized in table 1. The comparison of characteristics according to macronutrient quartiles (carbohydrate, fat, and protein) showed that HbA1c level was not significantly different between protein quartiles (p=0.330). Other variables were significantly different between all macronutrient quartiles (p<0.001). Compared with participants with low-carbohydrate intake, those with high-carbohydrate intake had higher total energy intake and lower fat intake. Moreover, they had higher values for age, HbA1c level, and PA. Compared with participants with low-fat intake, those with high-fat intake had lower total energy intake and lower carbohydrate intake. They also had lower values for age, HbA1c level, and PA.
Table 1

Characteristics of study participants by lowest quartile (Q) and highest macronutrient (carbohydrate, fat, and protein) intake

OverallCarbohydrate (%)Fat (%)Protein (%)
Q1 (lowest)Q4 (highest)Q1 (lowest)Q4 (highest)Q1 (lowest)Q4 (highest)
(n=55 084)(25.9–52.8)(60.2–71.5)(8.4–19.3)(27.5–55.9)(7.3–11.3)(13.8–23.4)
Age (years)55.6±9.154.1±9.157.0±8.957.2±8.653.8±9.455.4±9.056.3±9.0
Male (n)23 998 (43.6%)2599 (18.9)12 160 (88.3)7191 (52.2)5389 (39.1)3977 (28.9)8379 (60.9)
Height (cm)160.2±8.7160.1±8.4161.7±9.0164.3±8.2157.0±7.5164.2±8.4156.8±7.6
Weight (kg)59.1±10.958.8±10.861.2±11.363.3±10.655.9±9.862.9±11.056.3±9.9
BMI (kg/m²)23.0±3.222.8±3.223.3±3.323.4±3.122.6±3.323.3±3.222.8±3.3
Systolic blood pressure (mm Hg)128.2±19.9128.7±20.5128.8±19.3131.3±19.8125.7±19.8130.0±19.6127.6±20.1
Diastolic blood pressure (mm Hg)78.4±12.178.8±12.678.7±11.780.8±12.076.4±12.080.3±12.277.2±12.0
HbA1c (%)5.47±0.525.42±0.485.52±0.605.50±0.615.43±0.465.47±0.565.46±0.46
HbA1c (mmol/mol)36.3±5.735.7±5.336.8±6.636.6±6.635.9±5.036.3±6.236.2±5.1
PA (METs×hour/day)14.8±13.413.6±12.416.6±15.016.7±15.013.8±12.516.1±14.614.5±13.0
Total energy intake (kcal/day)1714±3601580±3661895±3951976±3911520±2981919±4171562±304
Carbohydrate (%)56.1±6.048.1±4.563.0±2.260.1±5.651.4±5.558.4±6.853.0±5.7
Fat (%)23.7±6.428.3±7.118.6±4.116.2±2.332.1±4.318.1±4.429.4±5.9
Protein (%)12.6±1.913.5±2.411.6±1.510.9±1.314.4±1.910.4±0.715.2±1.4
Current drinker (n)29 762 (53.7%)7408 (53.8)9380 (68.2)7826 (56.9)7055 (51.3)6832 (49.7)8201 (59.7)
Alcohol consumption amount* (g/day)11.9±16.710.9±16.713.7±17.412.9±17.611.4±16.411.2±16.513.0±17.5
Current smoker (n)9423 (17.1%)2256 (16.4)3378 (24.6)2880 (21.0)1982 (14.5)2309 (16.8)2632 (19.2)
Smoking amount† (cigarettes/day)19.2±9.817.7±10.220.2±9.519.8±9.819.1±10.518.3±9.620.4±9.8
Hypertension medicine (n)8202 (14.9%)1747 (12.7)2396 (17.4)2499 (18.2)1704 (12.4)2038 (14.8)2140 (15.6)
Cholesterol medicine (n)4812 (8.7%)1259 (9.2)958 (7.0)1340 (9.7)1021 (7.4)1348 (9.8)1074 (7.8)

Values are presented as mean±SD for continuous variables and number (%) for categorical variables.

Missing data on BMI (n=12), alcohol consumption (n=69), smoking (n=193), blood pressure (n=489), and medications (n=45).

*Mean alcohol (ethanol) consumption amount of current drinkers.

†Mean smoking amount of current smokers.

BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity.

Characteristics of study participants by lowest quartile (Q) and highest macronutrient (carbohydrate, fat, and protein) intake Values are presented as mean±SD for continuous variables and number (%) for categorical variables. Missing data on BMI (n=12), alcohol consumption (n=69), smoking (n=193), blood pressure (n=489), and medications (n=45). *Mean alcohol (ethanol) consumption amount of current drinkers. †Mean smoking amount of current smokers. BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity. Regarding the overall effects of PA or dietary intake on HbA1c level, we observed a weak inverse association between PA and HbA1c level and a significant positive association between total energy or carbohydrate intake and HbA1c level (table 2). No significant associations were observed between fat or protein intake.
Table 2

Effect of PA, total energy intake, and macronutrient (carbohydrate, fat, and protein) intake on HbA1c

βSEPtrend
PA (METs×hour/day)*−0.000330.000170.049
Total energy intake (kcal/day)†0.000020.000010.010
Carbohydrate (%)‡0.003930.00040<0.001
Fat (%)‡0.000040.000400.916
Protein (%)‡0.001060.001220.387

Regression analysis was conducted in the following units: PA, METs×hour/day; total energy intake, kcal/day; macronutrient intake, % of total energy intake; and HbA1c, %.

*Adjusted for age, sex, study area, total energy intake, macronutrient intake, alcohol consumption, smoking, medication for hypertension or hypercholesterolemia, and BMI.

†Adjusted for age, sex, study area, PA, macronutrient intake, alcohol consumption, smoking, medication for hypertension or hypercholesterolemia, and BMI.

‡Adjusted for age, sex, study area, total energy intake, PA, alcohol consumption, smoking, medication for hypertension or hypercholesterolemia, and BMI.

BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity; β, regression coefficient.

Effect of PA, total energy intake, and macronutrient (carbohydrate, fat, and protein) intake on HbA1c Regression analysis was conducted in the following units: PA, METs×hour/day; total energy intake, kcal/day; macronutrient intake, % of total energy intake; and HbA1c, %. *Adjusted for age, sex, study area, total energy intake, macronutrient intake, alcohol consumption, smoking, medication for hypertension or hypercholesterolemia, and BMI. †Adjusted for age, sex, study area, PA, macronutrient intake, alcohol consumption, smoking, medication for hypertension or hypercholesterolemia, and BMI. ‡Adjusted for age, sex, study area, total energy intake, PA, alcohol consumption, smoking, medication for hypertension or hypercholesterolemia, and BMI. BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity; β, regression coefficient. Table 3 shows the associations between PA and HbA1c level according to the quartiles of macronutrient intake. A tendency of interaction between PA and carbohydrate intake on HbA1c level was observed after adjusting for age, sex, study area, total energy intake, alcohol consumption, smoking, and medication for hypertension or hypercholesterolemia. (Pinteraction=0.054) (table 3, Carbohydrate, Model 1). Stratified analyses revealed that the associations between PA and HbA1c level did not reach statistical significance in participants with lower carbohydrate intake (Ptrend=0.636 and 0.917 in Q1 and Q2, respectively), whereas the inverse associations were significant in participants with higher carbohydrate intake (Ptrend=0.021 and 0.005 in Q3 and Q4, respectively). Further adjustment for BMI slightly attenuated the above interaction (Pinteraction=0.098) (table 3, Carbohydrate, Model 2). Similar to the result in model 1, the stratified analyses of model 2 revealed that the associations between PA and HbA1c level were not significant in participants with lower carbohydrate intake (Ptrend=0.679 and 0.786 in Q1 and Q2, respectively). Conversely, the inverse associations were significant in participants with higher carbohydrate intake (Ptrend=0.025 in both Q3 and Q4). There was a significant interaction between PA and fat intake on HbA1c level in model 1 (Pinteraction=0.006) (table 3, Fat, Model 1). Stratified analyses showed that the inverse association between PA and HbA1c level was significant in participants with lower fat intake (Ptrend<0.001 in Q1). However, the associations did not reach statistical significance in participants with higher fat intake (Ptrend=0.639, 0.849, and 0.741 in Q2, Q3, and Q4, respectively). Further adjustment for BMI slightly attenuated the above interaction (Pinteraction=0.068) (table 3, Fat, Model 2). Stratified analyses generated results with the same pattern as in model 1. Moreover, there was no significant interaction between PA and protein intake on HbA1c level (table 3, Protein).
Table 3

Associations between PA and HbA1c level by quartiles (Q) of macronutrient (carbohydrate, fat, and protein) intake

Model 1*Model 2†
βSEPtrend βSEPtrend
Carbohydrate (%)
 Q1 (25.9–52.8) (lowest)0.000170.000350.6360.000140.000350.679
 Q2 (52.8–56.7)0.000040.000340.9170.000090.000340.786
 Q3 (56.7–60.2)−0.000750.000320.021−0.000720.000320.025
 Q4 (60.2–71.5) (highest)−0.000820.000290.005−0.000650.000290.025
Pinteraction=0.054Pinteraction=0.098
Fat (%)
 Q1 (8.4–19.3) (lowest)−0.001210.00029<0.001−0.000940.000290.001
 Q2 (19.3–23.3)−0.000150.000330.639−0.000100.000320.747
 Q3 (23.3–27.5)0.000070.000350.8490.000000.000340.994
 Q4 (27.5–55.9) (highest)0.000120.000350.7410.000030.000340.934
Pinteraction=0.006Pinteraction=0.068
Protein (%)
 Q1 (7.3–11.3) (lowest)−0.000850.000300.005−0.000570.000300.054
 Q2 (11.3–12.5)−0.000370.000330.265−0.000310.000320.330
 Q3 (12.5–13.8)0.000170.000340.6150.000150.000340.660
 Q4 (13.8–23.4) (highest)−0.000310.000330.348−0.000400.000330.229
Pinteraction=0.156Pinteraction=0.427

Regression analysis was conducted in the following units: PA, METs×hour/day; HbA1c, %; and macronutrient intake, % of total energy intake.

*Model 1: adjusted for age, sex, study area, total energy intake, amount of alcohol consumption and smoking, and medication for hypertension or hypercholesterolemia.

†Model 2: adjusted for model 1+BMI.

BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity; β, regression coefficient.

Associations between PA and HbA1c level by quartiles (Q) of macronutrient (carbohydrate, fat, and protein) intake Regression analysis was conducted in the following units: PA, METs×hour/day; HbA1c, %; and macronutrient intake, % of total energy intake. *Model 1: adjusted for age, sex, study area, total energy intake, amount of alcohol consumption and smoking, and medication for hypertension or hypercholesterolemia. †Model 2: adjusted for model 1+BMI. BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity; β, regression coefficient. In the longitudinal study, there was a significant interaction between PA change and carbohydrate intake at baseline on the change of HbA1c level in model 1 (Pinteraction=0.026) (table 4, Carbohydrate, Model 1). Stratified analyses revealed that the association between PA change and HbA1c change was not significant in participants with lower carbohydrate intake (Ptrend=0.717 and 0.273 in Q1 and Q2, respectively), whereas a significant inverse association was observed in participants with higher carbohydrate intake (Ptrend=0.037 and 0.007 in Q3 and Q4, respectively). Further adjustment for BMI slightly attenuated the above interaction (Pinteraction=0.079) (table 4, Carbohydrate, Model 2). Although the interaction between PA change and fat intake on the change of HbA1c level was not statistically significant (Pinteraction=0.257) (table 4, Fat), stratified analyses showed a significant inverse association between PA change and HbA1c change in participants with lower fat intake (Ptrend=0.014 in Q1). However, no significant association was observed in participants with higher fat intake (Ptrend=0.235, 0.616, and 0.621 in Q2, Q3, and Q4, respectively). No significant interaction was noted between PA change and protein intake on the change of HbA1c level (table 4, Protein).
Table 4

Associations between objectively measured PA change and HbA1c change by quartiles (Q) of macronutrient (carbohydrate, fat, and protein) intake at baseline

Model 1*Model 2†
βSEPtrend βSEPtrend
Carbohydrate (%)
 Q1 (31.4–53.3) (lowest)−0.002850.007870.717−0.001290.007890.870
 Q2 (53.3–56.7)0.008370.007630.2730.006960.007760.370
 Q3 (56.7–59.8)−0.016970.008130.037−0.013850.008140.089
 Q4 (59.8–70.7) (highest)−0.022300.008200.007−0.019470.008170.017
Pinteraction=0.026Pinteraction=0.079
Fat (%)
 Q1 (9.2–19.5) (lowest)−0.017050.006930.014−0.015160.006910.028
 Q2 (19.5–23.4)−0.010150.008530.235−0.007260.008570.397
 Q3 (23.4–27.4)−0.004090.008150.616−0.005680.008270.493
 Q4 (27.4–50.9) (highest)0.004230.008550.6210.006480.008620.453
Pinteraction=0.257Pinteraction=0.277
Protein (%)
 Q1 (8.0–11.5) (lowest)−0.012470.007610.101−0.010060.007610.186
 Q2 (11.5–12.6)−0.008410.007540.265−0.006640.007560.380
 Q3 (12.6–13.8)−0.010430.008140.200−0.010930.008290.188
 Q4 (13.8–22.3) (highest)0.200200.008680.8340.002830.008690.745
Pinteraction=0.633Pinteraction=0.646

Regression analysis was conducted in the following units: PA, METs×hour/day; HbA1c, %; and macronutrient intake, % of total energy intake.

*Model 1: adjusted for age at baseline, sex, changes in each of total energy intake, macronutrients intake, alcohol consumption and smoking amount, and medication for each of diabetes, hypertension and hypercholesterolemia.

†Model 2: adjusted for model 1+BMI change.

BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity; β, regression coefficient.

Associations between objectively measured PA change and HbA1c change by quartiles (Q) of macronutrient (carbohydrate, fat, and protein) intake at baseline Regression analysis was conducted in the following units: PA, METs×hour/day; HbA1c, %; and macronutrient intake, % of total energy intake. *Model 1: adjusted for age at baseline, sex, changes in each of total energy intake, macronutrients intake, alcohol consumption and smoking amount, and medication for each of diabetes, hypertension and hypercholesterolemia. †Model 2: adjusted for model 1+BMI change. BMI, body mass index; HbA1c, hemoglobin A1c; METs, metabolic equivalents; PA, physical activity; β, regression coefficient.

Conclusions

This large-scale study revealed the effect of interactions between PA and carbohydrate or fat intake on HbA1c level in the general population. Our finding suggests that the effect of PA on HbA1c levels is modified by the intake of macronutrient composition. The inverse associations between PA and HbA1c level were more evident in participants with higher carbohydrate or lower fat intake than in participants with lower carbohydrate or higher fat intake. Moreover, these associations and interactions were reproduced in the longitudinal study. Regarding diet, our findings revealed the inverse associations between carbohydrate and fat intake (online supplemental table 1), which appeared as a complementary relationship. Participants with higher carbohydrate intake had lower fat intake, and participants with lower carbohydrate intake had higher fat intake. In participants with high-carbohydrate or low-fat intake, the associations between higher PA and lower HbA1c levels were more evident than those in participants with low-carbohydrate or high-fat intake. Analyses with fasting blood glucose levels as the outcome also showed similar associations to HbA1c (online supplemental table 2) (n=30 416). A previous short-term intervention study demonstrated that low-carbohydrate/high-fat diet decreased the beneficial effects of exercise intervention on blood glucose levels,15 which is consistent with our results. In the present study, the interactions between PA and macronutrient intake on HbA1c level were observed after adjusting for total energy intake. This indicates that the effect of PA on HbA1c levels is modified according to the intake of macronutrient composition independent of total energy intake. Dietary energy intake is based on energy-producing nutrients (carbohydrate, fat, and protein). Evidence to determine an appropriate composition without the effects of total energy intake is limited.27 28 Some intervention studies have limited specific nutrients, such as carbohydrate and fat,29 but the groups of limited nutrients have decrease total energy intake at the same time; therefore, it is unable to decide as the effect of specific nutrient limitation alone. The present study demonstrated that the effect of PA on HbA1c level is modified by the macronutrient (carbohydrate or fat) intake after adjusting for total energy intake. Although further adjustment for BMI slightly attenuated the above interaction in the present analyses, similar associations were observed between PA and HbA1c level in the stratified analyses. This result suggests that the effect of PA is modified by the intake of macronutrient composition, even without obesity-mediated effects. Although a strong association was demonstrated between obesity and type 2 diabetes,30 studies also show that the association differs according to ethnicity,31 and several Asians are known to have type 2 diabetes without obesity compared with other ethnic groups.32 33 Studies have also suggested that Asians have low storage capacity of subcutaneous fat,34 which increases free fatty acid levels and induces insulin resistance.35 Therefore, the effects of macronutrient composition were direct without obesity, and the BMI-mediated effect observed in the present analysis is considered small. Although the exact mechanisms underlying the interaction between PA and macronutrient intake remain unclear, some mechanisms can explain the findings of the present study. PA improves insulin sensitivity and increases glucose uptake into organs such as skeletal muscle.36–38 Regarding dietary macronutrients, it has been reported that high-fat diet reduces skeletal muscle glucose uptake39 and insulin secretion.40 High-fat intake might weaken the beneficial effect of PA on glucose uptake, due to which the association between PA and HbA1c level was not significant in our study participants with low-carbohydrate or high-fat intake. It has also been reported that a typical high-fat western diet worsened insulin resistance, whereas the traditional high-carbohydrate, low-fat Asian diet improved insulin sensitivity.41 In the present study, it is possible that insulin sensitivity was relatively high in participants with high-carbohydrate or low-fat intake, and increased PA might have further promoted glucose uptake compared with that in participants with low-carbohydrate or high-fat intake. Consequently, the inverse associations between PA and HbA1c level were more evident in participants with high-carbohydrate or low-fat intake than in participants with low-carbohydrate or high-fat intake. Lifestyle improvements in terms of diet and PA are effective in preventing type 2 diabetes.6–10 The American Diabetes Association and JDS guidelines recommend diet and PA modifications as the first step in diabetes care.27 28 However, the guidelines indicate that there is no ideal dietary composition of carbohydrate, fat, and protein and that individualized instructions are required. The present study findings suggest that increasing PA is particularly effective in reducing HbA1c levels among participants with high-carbohydrate intake (or low-fat intake) similar to that in Japanese whose staple food is rice. Conversely, among individuals who have difficulty in increasing PA for some reasons, decreasing carbohydrate intake may be effective in controlling HbA1c levels (online supplemental table 3). The adjusted means of HbA1c in the joint analysis of PA and macronutrient intake also support the above-mentioned concept (online supplemental table 4). Our study has several limitations. First, we used self-reported data derived from questionnaires to evaluate diet, which might not be as accurate as objectively measured values. Second, using the total PA, including daily living and leisure-time activity, the effects of differences in activity strength and frequency were not examined. Finally, our study targeted the general population; hence, the results are not applicable to people with diabetes (online supplemental table 5) (n=3366). More detailed examinations, such as evaluating the intensity and frequency of PA and the source and quality of foods, might help in developing more effective preventive and therapeutic approaches. In conclusion, this study demonstrates the effect of interaction between PA and carbohydrate and fat intake on HbA1c level in the general population. The findings of the present study suggest that the effect of PA on HbA1c levels or blood glucose is modified by the intake of macronutrient composition. The interaction between PA and macronutrient intake probably plays an important role in the control of glucose metabolism. The control of HbA1c could become more effective and sustainable by implementing an optimized diet and PA according to possible interactions as observed in this study.
  39 in total

1.  Development of data-based semi-quantitative food frequency questionnaire for dietary studies in middle-aged Japanese.

Authors:  S Tokudome; M Ikeda; Y Tokudome; N Imaeda; I Kitagawa; N Fujiwara
Journal:  Jpn J Clin Oncol       Date:  1998-11       Impact factor: 3.019

2.  Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S.

Authors:  Yeyi Zhu; Margo A Sidell; David Arterburn; Matthew F Daley; Jay Desai; Stephanie L Fitzpatrick; Michael A Horberg; Corinna Koebnick; Emily McCormick; Caryn Oshiro; Deborah R Young; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2019-09-19       Impact factor: 19.112

3.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.

Authors:  Iris Shai; Dan Schwarzfuchs; Yaakov Henkin; Danit R Shahar; Shula Witkow; Ilana Greenberg; Rachel Golan; Drora Fraser; Arkady Bolotin; Hilel Vardi; Osnat Tangi-Rozental; Rachel Zuk-Ramot; Benjamin Sarusi; Dov Brickner; Ziva Schwartz; Einat Sheiner; Rachel Marko; Esther Katorza; Joachim Thiery; Georg Martin Fiedler; Matthias Blüher; Michael Stumvoll; Meir J Stampfer
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

5.  GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels.

Authors:  Ayumi Kanno; Shun-Ichiro Asahara; Ayuko Furubayashi; Katsuhisa Masuda; Risa Yoshitomi; Emi Suzuki; Tomoko Takai; Maki Kimura-Koyanagi; Tomokazu Matsuda; Alberto Bartolome; Yushi Hirota; Norihide Yokoi; Yuka Inaba; Hiroshi Inoue; Michihiro Matsumoto; Kenichi Inoue; Takaya Abe; Fan-Yan Wei; Kazuhito Tomizawa; Wataru Ogawa; Susumu Seino; Masato Kasuga; Yoshiaki Kido
Journal:  JCI Insight       Date:  2020-05-07

Review 6.  Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010.

Authors:  Madelyn L Wheeler; Stephanie A Dunbar; Lindsay M Jaacks; Wahida Karmally; Elizabeth J Mayer-Davis; Judith Wylie-Rosett; William S Yancy
Journal:  Diabetes Care       Date:  2012-02       Impact factor: 19.112

7.  β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.

Authors:  Daisuke Yabe; Yutaka Seino; Mitsuo Fukushima; Susumu Seino
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

8.  International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values.

Authors:  Atsunori Kashiwagi; Masato Kasuga; Eiichi Araki; Yoshitomo Oka; Toshiaki Hanafusa; Hiroshi Ito; Makoto Tominaga; Shinichi Oikawa; Mitsuhiko Noda; Takahiko Kawamura; Tokio Sanke; Mitsuyoshi Namba; Mitsuru Hashiramoto; Takayuki Sasahara; Yoshihiko Nishio; Katsuhiko Kuwa; Kohjiro Ueki; Izumi Takei; Masao Umemoto; Masami Murakami; Minoru Yamakado; Yutaka Yatomi; Hatsumi Ohashi
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

9.  Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis.

Authors:  Satoru Kodama; Shiro Tanaka; Yoriko Heianza; Kazuya Fujihara; Chika Horikawa; Hitoshi Shimano; Kazumi Saito; Nobuhiro Yamada; Yasuo Ohashi; Hirohito Sone
Journal:  Diabetes Care       Date:  2013-02       Impact factor: 19.112

Review 10.  The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups.

Authors:  Amir Emadian; Rob C Andrews; Clare Y England; Victoria Wallace; Janice L Thompson
Journal:  Br J Nutr       Date:  2015-09-28       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.